Previous Article | Next Article 
J Virol, January 1998, p. 151-157, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Inactivation of the RNase Activity of Glycoprotein
Erns of Classical Swine Fever Virus Results in a
Cytopathogenic Virus
M. M.
Hulst,
F. E.
Panoto,
A.
Hoekman,
H.
G. P.
van Gennip, and
R. J. M.
Moormann*
Institute for Animal Science and Health
(ID-DLO), Research Branch Houtribweg, NL-8200 AB Lelystad, The
Netherlands
Received 17 June 1997/Accepted 1 October 1997
 |
ABSTRACT |
Envelope glycoprotein Erns of classical swine fever
virus (CSFV) has been shown to contain RNase activity and is involved
in virus infection. Two short regions of amino acids in the sequence of
Erns are responsible for RNase activity. In both regions,
histidine residues appear to be essential for catalysis. They were
replaced by lysine residues to inactivate the RNase activity. The
mutated sequence of Erns was inserted into the p10 locus of
a baculovirus vector and expressed in insect cells. Compared to intact
Erns, the mutated proteins had lost their RNase activity.
The mutated proteins reacted with Erns-specific
neutralizing monoclonal and polyclonal antibodies and were still able
to inhibit infection of swine kidney cells (SK6) with CSFV, but at a
concentration higher than that measured for intact Erns.
This result indicated that the conformation of the mutated proteins was
not severely affected by the inactivation. To study the effect of these
mutations on virus infection and replication, a CSFV mutant with an
inactivated Erns (FLc13) was generated with an infectious
DNA copy of CSFV strain C. The mutant virus showed the same growth
kinetics as the parent virus in cell culture. However, in contrast to
the parent virus, the RNase-negative virus induced a cytopathic effect
in swine kidney cells. This effect could be neutralized by rescue of
the inactivated Erns gene and by neutralizing polyclonal
antibodies directed against Erns, indicating that this
effect was an inherent property of the RNase-negative virus. Analyses
of cellular DNA of swine kidney cells showed that the RNase-negative
CSFV induced apoptosis. We conclude that the RNase activity of envelope
protein Erns plays an important role in the replication of
pestiviruses and speculate that this RNase activity might be
responsible for the persistence of these viruses in their natural host.
 |
INTRODUCTION |
Classical swine fever virus (CSFV),
bovine viral diarrhea virus (BVDV), and border disease virus belong to
the genus Pestivirus within the family
Flaviviridae (10). The viruses are structurally, antigenically, and genetically closely related. BVDV and border disease virus can infect ruminants and pigs. CSFV infections are restricted to pigs (6). Pestiviruses are small, enveloped, positive-stranded RNA viruses (23). The genome of
pestiviruses varies in length from 12.5 to 16.5 kb (1, 2, 7, 17, 19, 25, 26, 28, 32) and contains a single large open reading
frame (ORF) (1, 7, 8, 17, 26). The ORF is translated into a
polyprotein which is processed into mature proteins by viral and host
cell proteases (30). The envelope of the pestivirus virion
contains three glycoproteins, Erns, E1, and E2
(35). Animals infected with pestiviruses raise antibodies
against at least two viral glycoproteins, namely, Erns and
E2 (16, 34, 42). Inhibition studies with E2 and
Erns produced in insect cells showed that both envelope
proteins are indispensable for viral attachment and entry of
pestiviruses into susceptible cells (13). In the virion,
Erns is present as a homodimer with a molecular mass of
about 100 kDa (35). Erns lacks a membrane
anchor, and association with the envelope is accomplished by an
as-yet-unknown mechanism. Significant amounts of Erns are
secreted from infected cells (30). A unique feature is that
Erns, besides being an envelope protein, possesses RNase
activity (12, 31). Erns belongs to the family of
extracellular RNases consisting of several fungal (e.g., RNase
T2 and Rh) and plant (e.g., S glycoproteins of
Nicotiana alata) RNases (12, 31). These RNases
contain two homologous regions of 8 amino acids each which are spaced by 38 (Erns) nonhomologous amino acids and which form the
RNase active site. Histidine residues in both regions appear to be
essential for RNase catalysis (15).
The role of this RNase activity in the replication of pestiviruses or
in the pathogenesis of a pestivirus infection is an interesting issue
that, as yet, has not been studied. The availability of a recently
generated infectious DNA copy of CSFV strain C (24) has
given us the opportunity to study the effect of defined mutations in a
pestivirus genome. In this paper, we report the inactivation of the
RNase activity of Erns by mutagenesis. To characterize the
mutated proteins, we produced large amounts of them in insect cells
(12). By reverse genetics, we generated an RNase-negative
CSFV recombinant. The effect of the inactivation of the RNase activity
of Erns on the replication of CSFV in vitro was studied.
 |
MATERIALS AND METHODS |
Cells and viruses.
Swine kidney cells (SK6) (14)
were maintained as described previously (24). The
preparation of an SK6 cell line which constitutively expresses the
bacteriophage T7 RNA polymerase in the cytoplasm of the cell (SK6.T7a5)
was approximately the same as described for other stably transformed
cell lines (27) and is described in detail elsewhere
(36). SK6.T7a5 cells were grown in Dulbecco's minimal
essential medium supplemented with 5% fetal bovine serum (FBS),
antibiotics, and 10 mM histidinol. The parent (not mutated) recombinant
virus derived from an infectious DNA copy of CSFV strain C was
propagated as described previously (FLc133 [24],
renamed FLc2). FBS and cells were free of BVDV, and FBS was free of
anti-BVDV antibodies.
Autographa californica nuclear polyhedrosis virus and
recombinant A. californica nuclear polyhedrosis viruses were
propagated in the Spodoptera frugiperda cell line Sf21 as
described previously (10). Sf21 cells were grown as
monolayers in either TC100 medium (Gibco-BRL) supplemented with 10%
FBS and antibiotics or SF900 serum-free medium (Gibco BRL) plus
antibiotics.
Mutagenesis of the Erns gene by PCR.
In a first
PCR, a part of the Erns gene was amplified in a 35-cycle
reaction with Vent DNA polymerase (New England BioLabs) and a
baculovirus transfer vector containing the wild-type Erns
gene (12) as a template. In this reaction, primers in which the histidine codon (CAT) was substituted with a lysine codon (AAA) were used as forward primers: primer H>K(1), a
35-mer,
5'-GG-GTT-AAC-AGA-AGC-TTG-AAA-GGG-ATC-TGG-CCG-GGG-3' (nucleotides [nt] 1245 to 1279 in the sequence of CSFV strain C
[24]), and primer H>K(2), a 24-mer,
5'-GAA-TGG-AAC-AAA-AAA-GGA-TGG-TGT-3' (nt 1397 to 1421 [24]). A primer with a flanking BamHI site (underlined) (39 mer,
5'-ATAGTCGACGGATCCTTAGTACCCTATTTTCGTTGTCAC-3' [12]) was used as a reverse primer. PCR
fragments of the correct size were isolated from an agarose gel and
used in a second PCR to recover the complete Erns gene. In
this reaction, the noncoding DNA strand functions as a reverse primer
and the wild-type Erns gene with flanking BamHI
sites, isolated from the above-mentioned transfer vector and recloned
downstream of the bacteriophage T7 promoter in the BamHI
site of pGem4z-bleu, is used as a template. In this reaction, a T7
primer is used as a forward primer. The crude PCR products were
BamHI digested, and the 720-bp mutated Erns
genes were isolated from an agarose gel and fused to the signal sequence of glycoprotein gG of pseudorabies virus in the baculovirus transfer vector pAcAS3gX as described previously (11). A
transfer vector with an Erns gene in which the histidines
in both domains were substituted with lysines [H>K(1,2)] was
constructed as described above, except that, in the first PCR, the
transfer vector with the mutation in the second domain [H>K(2)] was
used as a template and the H>K(1) primer was used as a forward primer.
Cloning procedures and DNA manipulations were carried out essentially
as described previously (
24). DNA-modifying enzymes
were
used as specified by the manufacturers.
Escherichia coli DH5

was used for the propagation of plasmids and cDNA clones.
Construction and selection of baculovirus recombinants.
The
transfer vectors containing the mutated Erns genes were
used for insertion of Erns into the p10 locus of a
baculovirus vector (11). Recombinant viruses expressing the
mutated genes, named Bac[H>K(1)], Bac[H>K(2)], and
Bac[H>K(1,2)], were selected, and virus stocks were prepared as
described previously (11). Restriction enzyme analyses of chromosomal DNA isolated from Sf21 cells infected with wild-type and
recombinant baculoviruses showed that the Erns genes were
correctly inserted into the p10 locus of the baculovirus vector.
Characterization of Erns expressed in insect
cells.
The mutated proteins were purified from the lysate of Sf21
cells infected with the recombinant viruses H>K(1), H>K(2), and H>K(1,2) by immunoaffinity chromatography as described previously (12). The purified proteins were analyzed under reducing and nonreducing conditions by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). The RNase activity of the purified proteins
was measured as described previously (4). The RNase activity
was expressed as A260 units per minute per
milligram. Reactivity of the proteins with Erns-specific
monoclonal antibodies (MAb) C5, specifically directed against
Erns of CSFV strain C (41), and 140.1, directed
against Erns of CSFV strain C and Brescia (9),
and an Erns-specific polyclonal rabbit serum, 716, was
tested in a direct enzyme-linked immunosorbent assay (ELISA) as
described recently (12). Serum 716 was prepared by repeated
inoculation of a purified preparation of insect cell-produced
Erns from CSFV strain Brescia. The neutralizing antibody
titer (the reciprocal of the serum dilution neutralizing 100 50%
tissue culture infective doses (TCID50) of CSFV strain
Brescia [34]) of this serum was 75.
Interaction of proteins expressed in insect cells with the
surface of SK6 cells.
To determine whether the mutated
Erns proteins are able to inhibit infection of SK6 cells
with CSFV, inhibition assays were performed as described previously
(13). Inhibition was measured in a dose-dependent manner.
Briefly, confluent monolayers of SK6 cells grown in 2-cm2
tissue culture wells were preincubated with 100 µl of Earle's minimum essential medium (EMEM) containing different concentrations of
immunoaffinity-purified Erns. One hundred microliters of a
dilution of a stock of CSFV strain Brescia in EMEM (±500 PFU per well)
was added, and after 30 min of infection, the virus-Erns
mixture was removed and the cells were washed twice with 0.5 ml of
EMEM. The cells were supplied with complete medium containing 1%
methylcellulose, and after 24 h of growth, groups of infected cells (plaques) were detected by immunostaining (39) and
counted. The concentration at which 50% inhibition of infection was
achieved was extrapolated from an inhibition graph (number of plaques
[y axis] as function of the Erns concentration
[x axis]).
Construction of recombinant viruses FLc13, FLc20, and
FLc13R.
The mutated H>K(2) and H>K(1) genes were amplified in
PCRs as described above. In these reactions, the baculovirus transfer vectors containing the mutated Erns genes were used as
templates with primer 935 (5'-CCGAAAATATAACTCAATGG-3' [24]) as a forward primer and primer 925 (5'-CATAAGCGCCAAACCAGGTT-3' [24]) as a
reverse primer. Erns fragments were isolated from agarose
gels and phosphorylated with T4 DNA kinase (New England BioLabs).
Fragments were cloned in a calf intestinal phosphatase (New England
BioLabs)-treated StuI site of the transient expression
vector pPRKc5 (27, 37). This vector, a peVhisd12 derivative
(27), contains the nucleotide sequence of the autoprotease
and structural genes of CSFV strain C, without Erns
(Npro-C and E1-E2, amino acids 5 to 267 and amino acids 495 to 1063, respectively, of the nucleotide sequence of CSFV strain C
[24]). In pPRKc5, a unique StuI site was
introduced at the position where Erns was deleted. Clones
in which the mutated Erns genes were inserted in the
correct orientation were transfected to SK6 cells and tested for
expression of Erns and E2 by immunostaining as described
previously (37). Erns expression was detected
with MAb C5, and E2 expression was detected with MAb V3 (specifically
directed against E2 of CSFV [40]). From clones which
expressed both the Erns and the E2 genes,
pPRKc5.H>K(2) and pPRKc5.H>K(1), a ClaI-NgoMI fragment was isolated and inserted in the
ClaI-NgoMI-digested pPRKflc133 vector
(24). The resulting vectors, pPRKflc13 and pPRKflc20,
contain a full-length DNA copy of CSFV strain C with the genes H>K(2)
and H>K(1), respectively.
To rescue the RNase-negative virus FLc13, a wild-type E
rns
gene was amplified in a PCR with primers 935 and 925 (see above) and
pPRKflc133 (containing the wild-type E
rns gene
[
24]) as a template. This E
rns gene was
cloned in pPRKc5 as described above, and the resulting
vector, pPRKc10,
was tested for E
rns and E2 expression as described above.
The
ClaI-
NgoMI fragment
of pPRKflc13 was replaced
by a
ClaI-
NgoMI fragment isolated from
the
E
rns- and E2-expressing clone pPRKc10 to give pPRKflc13R.
Transfection and production of recombinant viruses FLc13, FLc20,
and FLc13R.
Plasmid DNA from pPRKflc13, pPRKflc20, and pPRKflc13R
was purified on columns (Qiagen) and linearized with XbaI.
The DNA was extracted with phenol-chloroform, precipitated with
ethanol, and dissolved in water. Linearized DNA (250 ng) was diluted in
20 µl of Optimem (Gibco-BRL) and mixed with 20 µl of Optimem
containing 2 µg of Lipofectin (Gibco-BRL). The DNA transfection
mixture was incubated at room temperature for 15 min. SK6.T7a5 cells,
grown in 2-cm2 tissue culture plates, were washed twice
with Optimem. Fresh Optimem (160 µl) was added, followed by the DNA
transfection mixture. After 16 h of incubation at 37°C, the
transfection mixture was removed and the wells were supplied with
complete medium. The cells were incubated for 4 days at 37°C, after
which the medium was stored at
70°C. Cells were immunostained with
MAb C5. The medium collected from wells in which Erns
expression was observed was used to infect SK6 cells. After three additional passages in SK6 cells, virus stocks were prepared as described previously (24). The titers (TCID50
per milliliter) of the virus stocks were determined by end-point
dilution.
Characterization of recombinant viruses.
Single-step growth
kinetics of the wild-type (not mutated) recombinant virus FLc2 and the
RNase-negative virus FLc13 were determined with SK6 cells. Confluent
monolayers of SK6 cells grown in 25-cm2 tissue culture
flasks were infected with a multiplicity of infection (MOI) of 2 to 5 TCID50 per cell for 1.5 h at 37°C. The virus was removed from the cells, and the cells were washed and supplied with
fresh medium. After 0, 24, 48, 72, and 96 h of growth, the cells
were frozen-thawed twice and clarified by centrifugation at 5,000 × g for 10 min. The virus titer (TCID50 per
milliliter) was determined by end-point dilution.
The virus neutralization index (log
10 reduction of the
virus titer [TCID
50 per milliliter] in the presence of a
neutralizing
serum [
39]) of the recombinant viruses
FLc2, FLc13, and FLc13R
was determined at a 1:25 dilution of serum 716 and a 1:100 dilution
of a polyclonal pig serum specifically directed
against E2 of
CSFV strain Brescia (serum 539; neutralizing antibody
titer, 1:4,800
[
11]) in an end-point dilution
titration.
The E
rns genes of the recombinant viruses FLc13 and FLc13R
were sequenced. For this test, confluent monolayers of SK6 cells grown
in 75-cm
2 tissue culture flasks were infected with FLc13
and FLc13R as
described above. After 72 h of growth, cytoplasmic
RNA was isolated
as described previously (
25) and used as a
template in standard
reverse transcription-PCR. The amplified DNA
fragments covering
the complete E
rns genes of FLc13 and
FLc13R were isolated from agarose gels and
directly sequenced with
E
rns flanking and internal primers by use of an ABI Ready
Reaction
Dye Terminator cycle sequencing kit (PE Applied Biosystems)
and
an ABI Prism 310 genetic analyzer (PE Applied Biosystems).
Total cellular DNA of SK6 cells infected with FLc2, FLc13, and FLc13R
was isolated after 24, 48, and 72 h of infection. SK6
cells were
infected as described above. The medium was removed
from the cells, and
the monolayers were lysed in 1 ml of ice-cold
lysis buffer (50 mM
Tris-Cl [pH 8.2], 140 mM NaCl, 2 mM MgCl
2,
0.5%
[vol/vol] Nonidet P-40, 0.5% [wt/vol] Na deoxycholate). Cells
in
the medium were recovered by centrifugation at 600 ×
g
for
10 min and lysed in the 1-ml lysate recovered from the wells.
An
equal volume of 100 mM Tris-Cl [pH 7.2]-25 mM EDTA-300 mM NaCl-2%
(wt/vol) SDS containing 200 µg of DNase-free proteinase K
(Boehringer)
per ml was added, and the extract was incubated for 2 h at 37°C.
DNA was extracted with phenol-chloroform and recovered by
ethanol
precipitation. RNase A-treated DNA (2 to 3 µg) was analyzed
on
a 1.5% agarose gel to detect DNA fragmentation.
Antigen capture RNase assay.
The RNase activity of
Erns expressed in SK6 cells infected with the recombinant
viruses FLc2 and FLc13 was measured by a modification of the method of
Brown and Ho (4). SK6 cells grown in 150-cm2
tissue culture flasks were infected with FLc2 and FLc13 as described above. After 72 h of growth, the cells were treated with trypsin, centrifuged for 10 min at 600 × g, and lysed in 1 ml
of ice-cold phosphate-buffered saline (PBS) containing 1% Nonidet
P-40. Each well of ELISA plates was coated with 100 µl of 50 mM
NaHCO3 (pH 9.65) containing 8 µg of MAb C5 per ml for
16 h at 37°C. The plates were washed with PBS containing 0.05%
Tween 80 and 0.2% bovine serum albumin. Dilutions of 100 µl of the
lysates in PBS containing 0.05% Tween 80 and 0.2% bovine serum
albumin were incubated in two separate plates for 2 h at 37°C.
After the plates were washed as described above, bound Erns
was detected in one of the two plates with an appropriate dilution of
horseradish peroxidase-conjugated MAb 140.1 in PBS containing 0.05%
Tween 80 and 4% horse serum. After the plate was washed, the bound
conjugate was detected with tetramethylbenzidine (Sigma) as a
substrate. The optical density was measured at 450 nm. The amount of
Erns bound in the wells was extrapolated with a standard
curve prepared from a purified preparation of Erns produced
in insect cells. To the wells of the second plate, 100 µl of reaction
buffer (50 mM succinate, 10 mM KCl [pH 4.5]) containing 2 mg of
Torula yeast RNA (Sigma) per ml was added. After incubation for 16 h at 37°C, the reaction mixture was transferred to a
reaction vessel with 20 µl of 25% (vol/vol) HClO4
containing 0.75% (wt/vol) uranyl acetate. After incubation on ice for
5 min, the contents of the reaction vessel were centrifuged for 5 min
at 10,000 × g, and 10 µl of the supernatant was
collected and diluted 10-fold with water. The
A260 was determined in a 100-µl, 10-mm
microcell with a Beckman DU spectrophotometer. The RNase activity was
expressed as A260 units per minute per
milligram. To account for background RNase activity, wells incubated
with a lysate prepared from mock-infected SK6 cells tested at the same
dilutions were assayed for RNase activity as described for FLc2 and
FLc13.
 |
RESULTS |
Characterization of mutated Erns proteins expressed in
insect cells.
Through chemical inactivation, Kawata et al.
(15) showed that the histidine residues in both domains of
RNase T2, which are homologous to Erns, were
essential for enzyme activity. To inactivate the RNase activity of
Erns, the histidine residue in the first and/or second
RNase domain was replaced by a lysine residue. In a two-step PCR, the
CAT codon at position 297 [H>K(1)] or the CAT codon at position 346 [H>K(2)] in the amino acid sequence of CSFV strain C (24)
was replaced by an AAA codon; alternatively, both codons were replaced
[H>K(1,2)]. In Fig. 1A, the
mutagenesis of the H>K(2) gene is depicted. Mutagenesis of the H>K(1)
and H>K(1,2) genes was essentially the same, except that different
primers or templates were used (see Materials and Methods). After
mutagenesis, the 720-bp mutated Erns genes were analyzed by
restriction enzyme digestion. Gel analyses showed that the mutated
genes lacked the NlaIII (CATG) site in the RNase domain that
corresponded to the primer used for mutagenesis (data not shown). The
mutated Erns genes were inserted into the p10 locus of
baculovirus as described previously (11). For all three
mutated genes, Erns-expressing recombinant viruses,
Bac[H>K(1)], Bac[H>K(2)], and Bac[H>K(1,2)], were selected and
plaque purified. The mutated Erns proteins and the
wild-type Erns protein expressed in insect cells
(12) were purified by immunoaffinity chromatography from the
lysate of Sf21 insect cells infected with these recombinant
baculoviruses. The purified proteins were immunologically and
biochemically characterized (Table 1).
Compared to wild-type Erns, the mutated proteins H>K(1),
H>K(2), and H>K(1,2) had no detectable RNase activity measured
between pHs 3.0 and 8.0 at 37°C or between 20 and 65°C at pH 4.5. Analyses of the purified proteins by SDS-PAGE under reducing and
nonreducing conditions showed that the mutated proteins had a mobility
similar to that of wild-type Erns and also were efficiently
dimerized. They also reacted identically with MAb and polyclonal
antibodies in a direct ELISA. Moreover, the mutated proteins were able
to inhibit infection of SK6 cells with CSFV strain Brescia but at a
concentration higher than that measured for wild-type Erns.
These results indicated that the conformation of the Erns
protein was not severely affected by the substitution of the histidine
residues with lysines and that the mutant proteins could still interact
with the surface of SK6 cells.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Mutagenesis of Erns H>K(2) by PCR. The
amino acid sequence of the first (1) and the second (2) RNase domains
are given in the one-letter code. a.a., amino acids in the ORF of
CSFV strain C (24). The histidine residues at positions 297 and 346 and the introduced lysine residue in the second domain (K) are
underlined. PCR primers are indicated by arrows. B, BamHI.
pAcAS3.gXCE2 was the template for the first PCR (baculovirus
transfer vector containing the nonmutated Erns gene
[12]). pGem4z-blue. Erns was the template
for the second PCR (containing the nonmutated Erns gene
recloned from pAcAS3.gXCE2 into the BamHI site downstream of
the bacteriophage T7 promoter of pGem4z-blue). (B) Scheme for the
construction of pPRKflc13, the full-length cDNA clone of CSFV strain C
containing the mutated Erns gene H>K(2). Npro,
autoprotease; C, core protein; E1 and E2, envelope proteins. The
pPRKc5.H>K(2) vector, containing the structural genes of CSFV strain C
(amino acids 5 to 1063 [24]), including the H>K(2)
substitution at position 346 (see panel A), transiently expressed
Erns and E2 in SK6 cells. pPRKflc133 is the nonmutated
full-length DNA copy of CSFV strain C in plasmid pOK12 (24).
phCMV is the promoter-enhancer sequence of the immediate-early gene of
human cytomegalovirus. T7p, bacteriophage T7 promoter. CIP, calf
intestinal phosphatase.
|
|
Construction and rescue of RNase-negative CSFV.
The
Erns gene of an infectious DNA copy of CSFV strain C was
replaced with the H>K(2) and H>K(1) genes as depicted in Fig. 1B for
H>K(2). The resulting full-length cDNAs, pPRKflc13 and pPRKflc20, respectively, were linearized by XbaI digestion and
transfected into an SK6 cell line which constitutively expresses the
bacteriophage T7 RNA polymerase in the cytoplasm of the cell (SK6.T7a5)
(36). Compared to viral positive-stranded sense RNA,
transcripts generated from the XbaI-linearized DNA copy have
an extension of 5 nt at the 3' terminus. However, these extended
transcripts are as infectious as transcripts with a correct 3' terminus
(24). Four days after transfection, infected SK6.T7a5 cells
were detected by immunostaining with Erns-specific MAb C5
for both full-length DNA copies. Moreover, SK6 cells were efficiently
infected with the medium collected from wells in which virus-infected
cells were detected. These results indicated that an infectious virus
with an inactivated H>K(2) or H>K(1) gene, designated FLc13 or FLc20,
respectively, was generated from pPRKflc13 and pPRKflc20.
In order to prepare a virus stock, FLc20 and FLc13 were passaged
totally five times in SK6 cells. In these successive passages,
SK6
monolayers infected with FLc13 and FLc20 appeared considerably
less
viable than monolayers infected with noncytopathogenic strain
C or with
wild-type strain C virus FLc2 derived from pPRKflc133.
SK6 cells
infected with these viruses cannot be distinguished
from mock-infected
cells. In end-point dilution titrations of
the prepared FLc13 and FLc20
virus stocks, clearly isolated groups
of spherical cells released from
the monolayers were observed
(shown for FLc13 after five passages in
SK6 cells) (Fig.
2A).
Immunostaining of
these infected monolayers with an E2-specific
MAb showed that at the
exact position on the monolayers where
these groups of cells were
observed, virus-infected cells could
be detected (Fig.
2B). These
results indicated that FLc13 and
FLc20 induced a cytopathogenic effect
in SK6 cells.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 2.
Cytopathogenic effect induced by FLc13. Groups of SK6
cells infected with FLc13 were observed in end-point dilution
titrations 96 h after infection before (A) and after (B)
immunostaining with a MAb directed against E2 of CSFV. (C) Monolayer of
SK6 cells infected with FLc13R before immunostaining. Immunostaining of
this monolayer demonstrated that 100% of the cells were infected (data
not shown).
|
|
To exclude the possibility that induction of this cytopathogenic effect
was caused by the introduction of unintended mutations
in the
full-length DNA sequence during the cloning procedures,
mutated
E
rns was rescued. The
ClaI-
NgoMI-digested pPRKflc13 vector was used
to
construct a full-length DNA copy with a wild-type E
rns gene
(cf. Fig.
1B). Transfection of the resulting vector, pPRKflc13R,
yielded a virus, FLc13R, that induced no cytopathogenic effect
in SK6
cells (after five passage in SK6 cells) (Fig.
2C).
Characterization of CSFV recombinant viruses.
Single-step
growth kinetics were determined for FLc2 and FLc13 (Fig.
3). FLc13 grows as fast and almost to the
same titer as FLc2. After 48 h, maximum titers of
106.5 TCID50/ml for FLc13 and 107
TCID50/ml for FLc2 were achieved. Since FLc20 grows to the
same titer in SK6 cells as FLc13 (results not shown), FLc20 was not further characterized.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 3.
Single-step growth kinetics of FLc2 and FLc13. Confluent
monolayers of SK6 cells were infected with an MOI of 2 to 5 TCID50 of FLc2 and FLc13 per cell for 1.5 h at 37°C.
The virus was removed, and fresh medium was added. After 0, 24, 48, 72, and 96 h of growth, the virus titer of the medium plus cells was
determined by end-point dilution.
|
|
To determine whether the mutated E
rns was incorporated in
the viral envelope, virus stocks of FLc2, FLc13, and FLc13R were
titrated
by end-point dilution in the presence or absence of
CSFV-neutralizing
antibodies. In Table
2,
the log
10 reduction of the virus titers
in the presence of
neutralizing antibodies (virus neutralization
index) for these viruses
are presented. Neutralization of FLc13
by E
rns-specific
polyclonal rabbit serum 716 indicated that the H>K(2)
protein was
incorporated in the viral envelope. However, FLc13
was neutralized less
by serum 716 than were FLc2 and the rescued
recombinant virus FLc13R.
All three recombinant viruses were neutralized
to the same extent by
E2-specific polyclonal serum 539. No cytopathogenic
effect was observed
in wells in which FLc13 was completely neutralized
by serum 716 or 539. These results indicated that the cytopathogenic
effect was an inherent
property of FLc13.
Sequence analysis of reverse transcription-PCR fragments covering the
complete E
rns genes of FLc13 and FLc13R showed that no
unintended mutations
were introduced in these genes. Moreover, the
introduced lysine
codon in the second RNase domain of FLc13
E
rns was still present (i.e., the histidine codon was
absent) after
five passages in SK6 cells.
The RNase activity of E
rns expressed by FLc2, FLc13, and
FLc13R was determined in an antigen capture RNase assay. On an ELISA
plate coated with E
rns-specific MAb C5, E
rns
was captured from the lysates of SK6 cells infected with FLc2
and
FLc13. Unbound proteins were washed away, and the RNase activity
of
bound E
rns proteins was measured as described by Brown and
Ho (
4). On
a duplicate plate, the amount of E
rns
captured by MAb C5 was estimated after detection with horseradish
peroxidase-conjugated MAb 140.1. In this assay, no significant
RNase
activity of the MAb C5-bound H>K(2) protein of FLc13 could
be measured
(Fig.
4). In contrast, the RNase
activities of bound
wild-type E
rns expressed by FLc2 and
FLc13R and expressed in insect cells were
comparable to the RNase
activities of unbound wild-type E
rns expressed in insect
cells (cf. Table
1).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
RNase specific activity (A260
min 1 mg 1) of Erns expressed by
FLc2, FLc13, and FLc13R but not of mutated Erns purified
from insect cells. Activity was measured at 37°C and pH 4.5 in an
antigen capture RNase assay.
|
|
Analyses of total cellular DNA of SK6 cells infected with
recombinant CSFV.
To obtain information about the mechanism
underlying the cytopathogenic effect observed in SK6 cells infected
with FLc13, total cellular DNA was extracted from SK6 cells infected
with FLc2, FLc13, and FLc13R. Spherical cells released from the
monolayers were recovered by centrifugation and extracted together with
monolayer-associated cells. Agarose gel analysis of the extracted DNA
showed that DNA isolated from SK6 cells infected with FLc13 was
fragmented to a characteristic DNA ladder faintly observed after
48 h and clearly observed after 72 h of infection (Fig.
5). No fragmentation was observed in DNA
extracted from SK6 cells infected with FLc2 and FLc13R. When DNA was
extracted from monolayer-associated SK6 cells infected with FLc13
(without spherical cells), no DNA fragmentation was observed (results
not shown). These results clearly indicated that the cytopathogenic
effect induced by the RNase-negative virus FLc13 was a result of
programmed cell death or apoptosis rather than necrosis.

View larger version (99K):
[in this window]
[in a new window]
|
FIG. 5.
DNA gel analysis. Confluent monolayers of SK6 cells were
infected with an MOI of 2 to 5 TCID50 of FLc2 (2), FLc13
(13), and FLc13R (13R) per cell for 1.5 h at 37°C. The virus was
removed, and fresh medium was added. After 0, 24, 48, and 72 h of
growth, cells released from the monolayer were recovered by
centrifugation and extracted together with monolayer-associated cells.
Extracted DNA (3 µg) was analyzed on a 1.5% agarose gel.
PstI-digested lambda DNA was run in parallel as a molecular
weight calibration ( PstI). M, mock-infected SK6 cells.
|
|
 |
DISCUSSION |
In this paper, we report the inactivation of the RNase activity of
envelope protein Erns of CSFV. As reported for fungal RNase
T2 (15), the histidines in both domains of
Erns are essential for RNase activity. Substitution of the
histidine residues in either of the two catalytic domains with lysine
residues completely inactivated the enzyme activity of the
Erns proteins expressed in insect cells.
Because there is a space of 38 amino acids between the domains
(12), strong interactions between amino acid residues of both domains are probably involved in the formation of the active site
of Erns (43). Moreover, the conformation of
Erns is probably dependent on the formation of this active
site. The RNase activity of Erns reaches a maximum between
pHs 4.5 and 6.5 (12, 43). To inactivate the enzyme activity
of Erns without destroying its conformation, the in an
acidic milieu positively charged histidine residues were replaced with
positively charged lysine residues. The reactivity of
Erns-specific antibodies with the inactivated
Erns proteins and the fact that these proteins were
efficiently dimerized and glycosylated demonstrated that this approach
was successful. It is likely that the interactions between amino acids
which are important for the conformation of Erns were not
affected by these substitutions.
The interaction of envelope protein Erns with the plasma
membrane is essential for pestivirus infection (13). To
ensure that the inactivated Erns proteins were still able
to interact properly with the cell surface to mediate infection, we
performed inhibition assays. All three inactivated Erns
proteins were able to inhibit infection of swine kidney cells with
CSFV. Furthermore, recombinant viruses FLc13 and FLc20, with the
inactivated H>K(2) and H>K(1) genes, respectively, were able to
infect swine kidney cells efficiently. FLc13 grows as fast and almost
to the same titer as wild-type virus FLc2 in swine kidney cells.
Together with the finding that FLc13 was neutralized by an
Erns-specific serum, these results indicated that the
H>K(2) protein was incorporated into the viral envelope and was able
to mediate infection as efficiently as wild-type Erns. The
threefold-higher concentration needed to achieve 50% inhibition and
the fact that FLc13 was neutralized less by an
Erns-specific serum than was FLc2, however, indicated that
there are at least some structural differences between H>K(2) and
wild-type Erns.
CSFV strain C (a vaccine strain [34]) is
noncytopathogenic in cell cultures. Therefore, we were surprised that
inactivation of the RNase activity of Erns resulted in the
production of cytopathogenic CSFV. To exclude the possibility that this
cytopathogenic effect was caused by the introduction of unwanted
mutations in the DNA copy of strain C, we replaced the H>K(2) gene
with the original Erns gene. The virus produced, FLc13R,
induced no cytopathogenic effect in swine kidney cells and could not be
distinguished from FLc2 by neutralization with
Erns-specific antibodies. The substitution of the histidine
with a lysine was a stable mutation. After five rounds of replication, the histidine codon was still absent in the viral RNA of FLc13, and
FLc13 still expressed an Erns protein [H>K(2)] that had
no detectable RNase activity. Therefore, we conclude that inactivation
of the RNase activity is responsible for the cytopathogenic character
of FLc13.
In tissue cultures, noncytopathogenic and cytopathogenic biotypes of
pestiviruses can be distinguished. The RNA genomes of the
noncytopathogenic biotypes are about 12.5 kb long (1, 17, 25,
26). Immunotolerant calves persistently infected with BVDV
sporadically develop mucosal disease (3, 5). In addition to
a noncytopathogenic BVDV strain, a cytopathogenic BVDV strain with a
considerably larger (2, 18, 19, 28, 32) or smaller (29,
33) RNA genome is always isolated from such calves. Molecular analyses of these isolates (virus pair) revealed that the
cytopathogenic biotype is formed by recombination of the
noncytopathogenic genome with cellular or viral RNA sequences (2,
19, 20, 32, 33). These recombination events provoke altered
protein processing of the nonstructural NS2-3 protein, resulting in the
expression or enhanced expression of NS3, generally accepted as the
cause for the induction of cytopathogenicity in vitro (2, 20, 32, 33). The majority of CSFV strains isolated from pigs are
noncytopathogenic in cell cultures. However, in a few cases, a
cytopathogenic pestivirus was isolated from pigs (22, 23).
Furthermore, after 230 passages of a noncytopathogenic CSFV isolate in
cell cultures, cytopathogenic defective interfering particles were
detected (22). The generation of defective interfering
particles with an infectious DNA copy of CSFV suggested that the
cytopathogenicity of these isolates can also be attributed to altered
expression of NS3 (21). Information about the mechanism by
which and the concentration in infected cells at which NS3 induces cell
lysis is as yet not available. NS3 is a multifunctional enzyme and
possesses serine protease, nucleoside triphosphatase, and RNA helicase
activities (38, 44). The enzyme activity of NS3 could play a
role in the induction of cell lysis. Recently, Zhang et al. reported
that the death of cells infected with a cytopathogenic BVDV strain was
mediated by apoptosis (45). They suggested that the
precursor of NS3, NS2-3, could block apoptosis in cells infected with
noncytopathogenic virus and that NS3 could inhibit this function of
NS2-3 in cells infected with cytopathogenic virus. DNA analyses showed
that the cytopathogenic effect induced by FLc13 is also a result of
apoptosis. As observed for FLc2, only NS2-3 and not NS3 could be
detected by radioimmunoprecipitation in the lysate of SK6 cells
infected with FLc13 (results not shown). Moreover, there was also no
decrease in the level of expression of NS2-3 for FLc13 compared to
FLc2. In general, cells infected with cytopathogenic pestiviruses
express detectable levels of NS3 and significantly more NS3 than do
cells infected with their noncytopathogenic counterparts (2, 20, 22, 32, 33). Therefore, we conclude that the induction of apoptosis by FLc13 most likely is not caused by altered expression of
NS3 and is the exclusive result of inactivation of the RNase activity
of Erns. It is likely that the RNase activity of
Erns prevents apoptosis and consequently cell lysis. If so,
the RNase activity of Erns probably plays a role in the
regulation of RNA synthesis in virus-infected cells. Because
Erns readily hydrolyzes CSFV-specific RNA of positive and
negative polarities (12, 43), it is unlikely that viral RNA
synthesis is affected by Erns. Most likely, cellular RNA
synthesis is down-regulated by Erns. In cells infected with
RNase-negative CSFV FLc13, the lack of down-regulation of cellular RNA
synthesis could result in an exceptionally high level of cell
metabolism. If sufficient nutrients or growth factors are not available
to support this higher level of metabolism, programmed cell death may
be induced. This hypothesis is in line with our observation that
mock-infected swine kidney cells spontaneously become apoptotic when
they were grown in EMEM with a low percentage of FBS (1%). More
studies have to be performed to elucidate the mechanism by which, at
which stage in the life cycle of pestiviruses, and in what cellular
compartment the RNase activity of Erns prevents apoptosis
in swine kidney cells.
Animal experiments have to be performed to find out whether
FLc13 also induces apoptosis in specific target cells of the natural host. If so, Erns, as suggested for NS2-3, might be a
prerequisite for the persistence of pestivirus strains in their natural
hosts. Because the RNase domains in Erns are homologous
with those in plant and fungal RNases (12), it seems likely
that the Erns gene or at least the two RNase domains were
acquired by pestiviruses through RNA recombination with cellular
sequences. Therefore, acquisition of this RNase activity might have
been important for the adaption of pestiviruses to their hosts and for
their survival in evolution.
 |
ACKNOWLEDGMENT |
We thank M. Widjojoatmodjo for critical reading of the
manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute for
Animal Science and Health (ID-DLO), Research Branch Houtribweg,
Houtribweg 39, P.O. Box 65, NL-8200 AB Lelystad, The Netherlands.
Phone: 31 320 238238. Fax: 31 320 238668. E-mail:
r.j.m.moormann{at}id.dlo.nl.
 |
REFERENCES |
| 1.
|
Becher, P.,
A. D. Shannon,
N. Tautz, and H.-J. Thiel.
1994.
Molecular characterization of border disease virus, a pestivirus from sheep.
Virology
198:542-551[Medline].
|
| 2.
|
Becher, P.,
G. Meyers,
A. D. Shannon, and H.-J. Thiel.
1996.
Cytopathogenicity of border disease virus is correlated with integration of cellular sequences into the viral genome.
J. Virol.
70:2992-2998[Abstract].
|
| 3.
|
Bolin, S. R.,
A. W. McClurkin,
R. C. Cutlip, and M. F. Coria.
1985.
Severe clinical disease induced in cattle persistently infected with noncytopathic bovine viral diarrhea virus by super-infection with cytopathic bovine viral diarrhea virus.
Am. J. Vet. Res.
46:573-576[Medline].
|
| 4.
|
Brown, P. H., and T. D. Ho.
1986.
Barley aleurone layers secrete a nuclease in response to gibberellic acid.
Plant Physiol.
82:801-806[Abstract/Free Full Text].
|
| 5.
|
Brownlie, J.,
M. C. Clarke, and C. J. Howard.
1984.
Experimental production of fatal mucosal disease in cattle.
Vet. Rec.
114:535-536[Abstract].
|
| 6.
|
Carbrey, E. A.,
W. C. Stewart,
J. L. Kresse, and M. L. Snijder.
1976.
Natural infection of pigs with bovine diarrhoea virus and its differential diagnosis from hog cholera.
J. Am. Vet. Med. Assoc.
169:1217-1219[Medline].
|
| 7.
|
Collett, M. S.,
R. Larson,
C. Gold,
D. Strick,
D. K. Anderson, and A. F. Purchio.
1988.
Molecular cloning and nucleotide sequence of the pestivirus bovine viral diarrhea virus.
Virology
165:191-199[Medline].
|
| 8.
|
Collett, M. S.,
R. Larson,
S. K. Belzer, and E. Petzel.
1988.
Proteins encoded by bovine viral diarrhea virus: the genomic organization of a pestivirus.
Virology
165:200-208[Medline].
|
| 9.
| de Smit, H. Unpublished data.
|
| 10.
|
Francki, R. I. B.,
C. M. Fauquet,
D. L. Knudson, and F. Brown.
1991.
Flaviviridae.
Arch. Virol. Suppl.
2:223-233.
|
| 11.
|
Hulst, M. M.,
D. F. Westra,
G. Wensvoort, and R. J. M. Moormann.
1993.
Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera.
J. Virol.
67:5435-5442[Abstract/Free Full Text].
|
| 12.
|
Hulst, M. M.,
G. Himes,
E. Newbigin, and R. J. M. Moormann.
1994.
Glycoprotein E2 of classical swine fever virus: expression in insect cells and identification as a ribonuclease.
Virology
200:558-565[Medline].
|
| 13.
| Hulst, M. M., and R. J. M. Moormann.
Inhibition of pestivirus infection in cell culture by envelope proteins
Erns and E2 of classical swine fever virus:
Erns and E2 interact with different receptors. J. Gen.
Virol., in press.
|
| 14.
|
Kasza, L.,
J. Shadduck, and G. Christofinis.
1972.
Establishment, viral susceptibility, and biological characteristics of a swine kidney cell line, SK-6.
Res. Vet. Sci.
13:46-51[Medline].
|
| 15.
|
Kawata, Y.,
F. Sakiyama, and H. Tamaoki.
1988.
Amino-acid sequence of ribonuclease T2 from Aspergillus oryzae.
Eur. J. Biochem.
176:683-697[Medline].
|
| 16.
|
Kwang, J.,
E. Littledike,
R. Donis, and E. Dubovi.
1992.
Recombinant polypeptide from the gp48 region of the bovine viral diarrhoea virus (BVDV) detects serum antibodies in vaccinated and infected cattle.
Vet. Microbiol.
32:281-292[Medline].
|
| 17.
|
Meyers, G.,
T. Rümenapf, and H.-J. Thiel.
1989.
Molecular cloning and the nucleotide sequence of the genome of hog cholera virus.
Virology
171:555-567[Medline].
|
| 18.
|
Meyers, G.,
T. Rümenapf, and H.-J. Thiel.
1989.
Ubiquitin in a togavirus.
Nature (London)
341:491[Medline].
|
| 19.
|
Meyers, G.,
N. Tautz,
E. J. Dubovi, and H.-J. Thiel.
1991.
Viral cytopathogenicity correlated with integration of ubiquitin-coding sequences.
Virology
180:602-616[Medline].
|
| 20.
|
Meyers, G.,
N. Tautz,
R. Stark,
J. Brownlie,
E. J. Dubovi,
M. S. Collett, and H.-J. Thiel.
1992.
Rearrangement of viral sequences in cytopathogenic pestiviruses.
Virology
191:368-386[Medline].
|
| 21.
|
Meyers, G.,
H.-J. Thiel, and T. Rümenapf.
1996.
Classical swine fever virus: recovery of infectious viruses from cDNA constructs and generation of recombinant cytopathogenic defective interfering particles.
J. Virol.
70:763-770[Abstract].
|
| 22.
|
Meyers, G., and H.-J. Thiel.
1995.
Cytopathogenicity of classical swine fever virus caused by defective interfering particles.
J. Virol.
69:3683-3689[Abstract].
|
| 23.
|
Moennig, V.
1988.
Characteristics of the virus, p. 55-88. In
B. Liess (ed.), Classical swine fever and related viral infections.
Martinus Nijhoff Publishing, Boston, Mass.
|
| 24.
|
Moormann, R. J. M.,
H. G. P. van Gennip,
G. K. W. Miedema,
M. M. Hulst, and P. A. van Rijn.
1996.
Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus.
J. Virol.
70:763-770.
|
| 25.
|
Moormann, R. J. M., and M. M. Hulst.
1988.
Hog cholera virus: identification and characterization of the viral RNA and the virus-specific RNA synthesized in infected swine kidney cells.
Virus Res.
11:281-291[Medline].
|
| 26.
|
Moormann, R. J. M.,
P. A. M. Warmerdam,
B. van der Meer,
W. Schaaper,
G. Wensvoort, and M. M. Hulst.
1990.
Molecular cloning and nucleotide sequence of hog cholera virus strain Brescia and mapping of the genomic region encoding envelope protein E1.
Virology
177:184-198[Medline].
|
| 27.
|
Peeters, B.,
N. De Wind,
M. Hooisma,
F. Wagenaar,
A. Gielkens, and R. Moormann.
1992.
Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion.
J. Virol.
66:894-905[Abstract/Free Full Text].
|
| 28.
|
Qi, F.,
J. F. Ridpath,
T. Lewis,
S. R. Bolin, and E. Berry.
1992.
Analysis of the bovine viral diarrhea virus genome for possible cellular insertions.
Virology
189:285-292[Medline].
|
| 29.
|
Renard, A.,
C. Guiot,
D. Schmetz,
L. Dagenias,
P. P. Pastoret,
D. Dina, and J. A. Martial.
1985.
Molecular cloning of bovine viral diarrhea viral sequences.
DNA
4:429-438[Medline].
|
| 30.
|
Rümenapf, T.,
G. Unger,
J. H. Strauss, and H.-J. Thiel.
1993.
Processing of the envelope glycoproteins of pestiviruses.
J. Virol.
67:3288-3294[Abstract/Free Full Text].
|
| 31.
|
Schneider, R.,
G. Unger,
R. Stark,
E. Schneider-Scherzer, and H.-J. Thiel.
1993.
Identification of a structural glycoprotein of an RNA virus as a ribonuclease.
Science
261:1169-1171[Abstract/Free Full Text].
|
| 32.
|
Tautz, N.,
G. Meyers,
R. Stark,
E. D. Dubovi, and H.-J. Thiel.
1996.
Cytopathogenicity of a pestivirus correlated with a 27-nucleotide insertion.
J. Virol.
70:7851-7858[Abstract].
|
| 33.
|
Tautz, N.,
G. Meyers,
E. D. Dubovi, and H.-J. Thiel.
1994.
Pathogenesis of mucosal disease: a cytopathogenic pestivirus generated by an internal deletion.
J. Virol.
68:3289-3297[Abstract/Free Full Text].
|
| 34.
|
Terpstra, C., and G. Wensvoort.
1988.
The protective value of vaccine-induced neutralizing antibody titres in swine fever.
Vet. Microbiol.
16:123-128[Medline].
|
| 35.
|
Thiel, H.-J.,
R. Stark,
E. Weiland,
T. Rümenapf, and G. Meyers.
1991.
Hog cholera virus: molecular composition of virions from a pestivirus.
J. Virol.
65:4705-4712[Abstract/Free Full Text].
|
| 36.
| Van Gennip, H. G. P., P. A. van Rijn, and
R. J. M. Moormann. Unpublished data.
|
| 37.
|
Van Rijn, P. A.,
H. G. P. Van Gennip,
E. J. de Meijer, and R. J. M. Moormann.
1993.
Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia.
J. Gen. Virol.
74:2053-2060[Abstract/Free Full Text].
|
| 38.
|
Warrener, P., and M. S. Collett.
1995.
Pestivirus NS3 (p80) protein possesses RNA helicase activity.
J. Virol.
69:1720-1726[Abstract].
|
| 39.
|
Wensvoort, G.,
C. Terpstra,
J. Boonstra,
M. Bloemraad, and D. van Zaane.
1986.
Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosis.
Vet. Microbiol.
12:101-108[Medline].
|
| 40.
|
Wensvoort, G.
1989.
Topographical and functional mapping of epitopes on hog cholera virus with monoclonal antibodies.
J. Gen. Virol.
70:2865-2876[Abstract/Free Full Text].
|
| 41.
|
Wensvoort, G.
1989.
.
Epitopes on structural proteins of hog cholera (swine fever) virus. Ph.D. thesis.
State University of Utrecht, Utrecht, The Netherlands.
|
| 42.
|
Wensvoort, G.,
J. Boonstra, and B. Bodzinga.
1990.
Immuno-affinity purification of envelope protein E1 of hog cholera virus.
J. Gen. Virol.
71:531-540[Abstract/Free Full Text].
|
| 43.
|
Windisch, J. M.,
R. Schneider,
R. Stark,
E. Weiland,
G. Meyers, and H.-J. Thiel.
1996.
RNase of classical swine fever virus: biochemical characterization and inhibition by virus-neutralizing monoclonal antibodies.
J. Virol.
70:352-358[Abstract].
|
| 44.
|
Wiskerchen, M., and M. S. Collett.
1991.
Pestivirus gene expression: protein p80 of bovine viral diarrhea virus is a proteinase involved in polyprotein processing.
Virology
184:341-350[Medline].
|
| 45.
|
Zhang, G.,
S. Aldridge,
M. C. Clarke, and J. W. McCauley.
1996.
Cell death induced by cytopathic bovine diarrhoea virus is mediated by apoptosis.
J. Gen. Virol.
77:1677-1681[Abstract/Free Full Text].
|
J Virol, January 1998, p. 151-157, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gallei, A., Blome, S., Gilgenbach, S., Tautz, N., Moennig, V., Becher, P.
(2008). Cytopathogenicity of Classical Swine Fever Virus Correlates with Attenuation in the Natural Host. J. Virol.
82: 9717-9729
[Abstract]
[Full Text]
-
Meyers, G., Ege, A., Fetzer, C., von Freyburg, M., Elbers, K., Carr, V., Prentice, H., Charleston, B., Schurmann, E.-M.
(2007). Bovine Viral Diarrhea Virus: Prevention of Persistent Fetal Infection by a Combination of Two Mutations Affecting Erns RNase and Npro Protease. J. Virol.
81: 3327-3338
[Abstract]
[Full Text]
-
Risatti, G. R., Borca, M. V., Kutish, G. F., Lu, Z., Holinka, L. G., French, R. A., Tulman, E. R., Rock, D. L.
(2005). The E2 Glycoprotein of Classical Swine Fever Virus Is a Virulence Determinant in Swine. J. Virol.
79: 3787-3796
[Abstract]
[Full Text]
-
Gallei, A., Rumenapf, T., Thiel, H.-J., Becher, P.
(2005). Characterization of Helper Virus-Independent Cytopathogenic Classical Swine Fever Virus Generated by an In Vivo RNA Recombination System. J. Virol.
79: 2440-2448
[Abstract]
[Full Text]
-
Lin, M., Trottier, E., Pasick, J.
(2005). Antibody Responses of Pigs to Defined Erns Fragments after Infection with Classical Swine Fever Virus. CVI
12: 180-186
[Abstract]
[Full Text]
-
Lin, M., Trottier, E., Pasick, J., Sabara, M.
(2004). Identification of Antigenic Regions of the Erns Protein for Pig Antibodies Elicited during Classical Swine Fever Virus Infection. J Biochem
136: 795-804
[Abstract]
[Full Text]
-
van Gennip, H. G. P., Vlot, A. C., Hulst, M. M., de Smit, A. J., Moormann, R. J. M.
(2004). Determinants of Virulence of Classical Swine Fever Virus Strain Brescia. J. Virol.
78: 8812-8823
[Abstract]
[Full Text]
-
von Freyburg, M., Ege, A., Saalmuller, A., Meyers, G.
(2004). Comparison of the effects of RNase-negative and wild-type classical swine fever virus on peripheral blood cells of infected pigs. J. Gen. Virol.
85: 1899-1908
[Abstract]
[Full Text]
-
Iqbal, M., Poole, E., Goodbourn, S., McCauley, J. W.
(2004). Role for Bovine Viral Diarrhea Virus Erns Glycoprotein in the Control of Activation of Beta Interferon by Double-Stranded RNA. J. Virol.
78: 136-145
[Abstract]
[Full Text]
-
Iqbal, M., McCauley, J. W.
(2002). Identification of the glycosaminoglycan-binding site on the glycoprotein Erns of bovine viral diarrhoea virus by site-directed mutagenesis. J. Gen. Virol.
83: 2153-2159
[Abstract]
[Full Text]
-
Meyer, C., von Freyburg, M., Elbers, K., Meyers, G.
(2002). Recovery of Virulent and RNase-Negative Attenuated Type 2 Bovine Viral Diarrhea Viruses from Infectious cDNA Clones. J. Virol.
76: 8494-8503
[Abstract]
[Full Text]
-
Hulst, M. M., van Gennip, H. G. P., Vlot, A. C., Schooten, E., de Smit, A. J., Moormann, R. J. M.
(2001). Interaction of Classical Swine Fever Virus with Membrane-Associated Heparan Sulfate: Role for Virus Replication In Vivo and Virulence. J. Virol.
75: 9585-9595
[Abstract]
[Full Text]
-
Lin, M., Lin, F., Mallory, M., Clavijo, A.
(2000). Deletions of Structural Glycoprotein E2 of Classical Swine Fever Virus Strain Alfort/187 Resolve a Linear Epitope of Monoclonal Antibody WH303 and the Minimal N-Terminal Domain Essential for Binding Immunoglobulin G Antibodies of a Pig Hyperimmune Serum. J. Virol.
74: 11619-11625
[Abstract]
[Full Text]
-
Hulst, M. M., van Gennip, H. G. P., Moormann, R. J. M.
(2000). Passage of Classical Swine Fever Virus in Cultured Swine Kidney Cells Selects Virus Variants That Bind to Heparan Sulfate due to a Single Amino Acid Change in Envelope Protein Erns. J. Virol.
74: 9553-9561
[Abstract]
[Full Text]
-
Widjojoatmodjo, M. N., van Gennip, H. G. P., Bouma, A., van Rijn, P. A., Moormann, R. J. M.
(2000). Classical Swine Fever Virus Erns Deletion Mutants: trans-Complementation and Potential Use as Nontransmissible, Modified, Live-Attenuated Marker Vaccines. J. Virol.
74: 2973-2980
[Abstract]
[Full Text]
-
Meyers, G., Saalmüller, A., Büttner, M.
(1999). Mutations Abrogating the RNase Activity in Glycoprotein Erns of the Pestivirus Classical Swine Fever Virus Lead to Virus Attenuation. J. Virol.
73: 10224-10235
[Abstract]
[Full Text]
-
Tautz, N., Harada, T., Kaiser, A., Rinck, G., Behrens, S.-E., Thiel, H.-J.
(1999). Establishment and Characterization of Cytopathogenic and Noncytopathogenic Pestivirus Replicons. J. Virol.
73: 9422-9432
[Abstract]
[Full Text]